Exocrine Pancreatic Insufficiency - Pipeline Review, H2 Pharmaceutical 2016
"Exocrine Pancreatic Insufficiency - Pipeline Review, H2 2016" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Exocrine Pancreatic Insufficiency - Pipeline Review, H2 2016, provides an overview of the Exocrine Pancreatic Insufficiency (Gastrointestinal) pipeline landscape. Exocrine pancreatic insufficiency (EPI) is a condition characterized by deficiency of the exocrine pancreatic enzymes, resulting in the inability to digest food properly, or maldigestion. Symptoms include diarrhea, loose, oily stools with unabsorbed fat (steatorrhea), vitamin deficiencies, loss of appetite, and unexplained weight loss. Treatment includes pancreatic enzyme replacement therapy (PERT) and lifestyle modifications. Get Sample Report With TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid=896051